# UNeHealth UNeHealth is the contracting and fiscal arm for industry-funded clinical trials on behalf of University of Nebraska Medical Center. It is housed under Center for Clinical and Translational Research (CCTR), operating under the direction of Dr. Russell McCulloh, Chief Medical Officer for UNeHealth and Associate Vice Chancellor for Clinical Research. Contract Types Handled by UNeHealth: - CDAs (non-disclosure agreements) - Clinical trial agreements involving investigational drugs or devices - Master clinical trial agreements - Compassionate use agreements - Emergency use agreements - PI-initiated clinical trial agreements - Material transfer of drug related to patient-oriented research or compassionate use
[](https://www.unmc.edu/vcr/_documents/funding-spa/unehealth-guidebook.pdf) [](#bkmrk-info) [](#bkmrk-faq)
--- ## Submit a New Contract All new clinical trial submissions are to be submitted through the CRC. Instructions for submission can be found on their [Intake Form page](https://www.unmc.edu/research-resources/clinical-research/study-intake.html). The following documents will be required by UNeHealth to begin negotiation: - Editable contract template from sponsor - Protocol Your email communication with the sponsor may also provide valuable information to UNeHealth to help ensure timely negotiation. Consult the [UNeHealth Guidebook](https://www.unmc.edu/vcr/_documents/funding-spa/unehealth-guidebook.pdf) for additional information. ## UNeHealth Information for Sponsors (Tax ID, etc) Sponsors typically require information from sites for the purpose of setting up contract templates, vendor payment systems, etc. In most cases, they request this information from clinical coordinators, so it is important for coordinators to understand that the information for UNeHealth contracts is different than for UNMC contracts. Please share UNeHealth information for the following when working with an industry sponsor: - CDAs (non-disclosure agreements) - Clinical trial agreements involving investigational drugs or devices - Master clinical trial agreements - Compassionate use agreements - Emergency use agreements - PI-initiated clinical trial agreements - Material transfer of drug related to patient-oriented research or compassionate use Exceptions: All new master clinical trial agreements will be through UNeHealth, but existing UNMC masters are still in use until they can be converted.
UNeHealth Information
Parties to AgreementUNeHealth and Board of Regents, acting by and behalf of the University of Nebraska Medical Center
Indirect Rate30% (From [UNMC's Negotiated Rate](https://guides.unmc.edu/books/sponsored-programs-administration-guidebook/page/institutional-information#bkmrk-idc-rates) for Industry-Sponsored Clinical Trials)
Fringe Benefit Rate[Standard UNMC Rates](https://guides.unmc.edu/books/sponsored-programs-administration-guidebook/page/institutional-information#bkmrk-benefits)
Legal NameUNeHealth
Organization TypeNon-profit ancillary organization of the University of Nebraska formed by UNMC, authorized by the Board of Regents
PayeeUNeHealth
Payee TypeUNeHealth is the fiscal arm of the University of Nebraska Medical Center for the conduct of clinical trials
Financial Official Payment AddressCharles Miller Accounting Manager 985090 Nebraska Medical Center Omaha, NE 68198-5090 Phone: 402-559-5825 email:
EIN/Federal Tax ID47-0771713
W-9[UNeHealth W9](https://www.unmc.edu/vcr/_documents/funding-spa/unehealth-w9.pdf "UNMC W9") (Effective 1/1/22) Contact UNeHealth Contract Associate
Contracting AddressUNeHealth Attn: Russell McCulloh, MD 985331 Nebraska Medical Center Omaha, NE 68198-5331 Phone: 402-559-7614 email:
Human Subject Assurance NumberFWA 00002939
NPI Number1790042786
## Frequently Asked Questions
Who invoices for UNeHealth studies? SPA Accounting invoices for start-up costs and IRB fees unless other arrangements have been made between the Department and SPA Accounting. All other invoices are submitted by the Department Administrator who ensures the Study WBS is reconciled regularly.
Why is a CDA necessary? Who signs? Confidential Disclosure Agreements (CDAs), are completed at the beginning of the Study review process to allow the PI to receive proprietary information (normally the Protocol and Investigator’s Brochure) related to the Study. Without a CDA, the recipients of confidential information are not prohibited from using and disclosing any confidential information received. Sponsor’s want to ensure that any such confidential information is appropriately protected. A UNMC Authorized Signatory should sign CDA’s. If the PI is the party to and signs the CDA, they bear the responsibility and obligations of ensuring that all of the agreement terms are followed.
If we choose to use an external IRB for a study, how do they get paid? Ideally, the Sponsor will work directly with the external IRB, which will submit all invoices directly to the Sponsor. However, there have been Sponsors who choose how to work directly or indirectly with an external IRB, so UNMC and/or the department has to act as the middle man. This is important to consider when deciding which IRB to use, as departments must weigh the costs of taking on those invoicing and payment responsibilities.
What if the Study is closed to enrollment, and the IRB is expiring, but all final payments have not been received, does the IRB have to be extended? No, as long as there are no further activities taking place related to patient information. At this time, SPA Accounting will likely lock the account to new expenses, but keep it open to receive new revenue.
Is cost sharing allowed on an industry-sponsored clinical trial? No, not without a waiver which requires justification and approval. F&A Waivers are considered on a case-by-case basis by the Vice Chancellor for Research. [Download](https://www.unmc.edu/vcr/_documents/funding-spa/fa-waiver.doc) the F&A Waiver Form.
How can the PI and Department help with Contract negotiations? When asked, the PI and Department can be of help with communicating with the Sponsor.